PathAI is a leading provider of AI-powered precision pathology solutions, dedicated to improving patient outcomes through reliable AI-powered technology and meaningful collaboration with biopharma, laboratories, and clinicians. The core product is AISight®, a cloud-native intelligent enterprise workflow solution that serves as a central hub for case management, image management, and best-in-class artificial intelligence tools to enable end-to-end digital pathology workflows.
Key Capabilities & Use Cases:
- AI-Powered Diagnostics: The platform uses sophisticated AI algorithms, trained on vast datasets of pathology images and millions of annotations, to automatically analyze pathology slides, identify key markers, and quantify biomarkers (e.g., PD-L1, HER2). This helps to enhance diagnostic precision and efficiency by minimizing human error.
- Drug Development & Clinical Trials: PathAI provides comprehensive support for biopharma, including translational research tools for biomarker discovery, custom algorithm development, and GCP/GCLP-compliant lab services. The technology aids in matching patients with the most effective treatments by identifying specific biomarkers for clinical trial selection.
- Digital Workflow Management: AISight is a browser-accessible, cloud-based platform that integrates seamlessly with existing Laboratory Information Systems (LIS). Features like the "Intelligent Caselist" allow for AI-assisted case prioritization, and "AISight Live" enables real-time, multi-institutional collaboration and remote case review.
- Open AI Environment: The platform supports an open environment, allowing for the integration of AI algorithms from PathAI's own portfolio and third-party partners via the AISight Link API.
PathAI's mission is to transform pathology by developing AI models that optimize the analysis of patient tissue samples, ultimately accelerating drug approvals and improving confidence in the accuracy of diagnosis.